Loading…
Alcon Inc. is projected to rise to $84.87 by 2027, a +25% move from its current price of $67.81. ALC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $66.91 | $67.86 | $68.82 | +0.07% |
| Jul 13 | $66.57 | $67.91 | $69.28 | +0.15% |
| Jul 14 | $66.32 | $67.96 | $69.64 | +0.22% |
| Jul 15 | $66.11 | $68.01 | $69.96 | +0.29% |
| Jul 16 | $65.94 | $68.06 | $70.24 | +0.36% |
| Jul 17 | $65.79 | $68.11 | $70.50 | +0.44% |
| Jul 18 | $65.66 | $68.16 | $70.75 | +0.51% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $65.66 | $68.16 | $70.75 | +0.51% |
| Week 2 | $64.98 | $68.50 | $72.22 | +1.02% |
| Week 3 | $64.54 | $68.85 | $73.46 | +1.54% |
| Week 4 | $64.22 | $69.21 | $74.58 | +2.06% |
| Week 5 | $63.98 | $69.56 | $75.62 | +2.58% |
| Week 6 | $63.80 | $69.91 | $76.61 | +3.10% |
| Week 7 | $63.66 | $70.27 | $77.57 | +3.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care, and it offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
The cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. The company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers.
The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Alcon Inc. is a healthcare company in the eye care sector, with two main operating segments, Surgical and Vision Care. It develops and sells a broad range of ophthalmic devices, implants, and consumables designed for surgical procedures and eye health.
The stock trades in the healthcare space with a current price of $69.66 and a market capitalization of $33.97B, ranking 405 by market size. The multi-year forecast shows a bullish trajectory beyond 2026, with the average price rising to $111.06 by 2030 and $471.59 by 2050, corresponding to ROIs of 59.4% and 577% respectively. In the near term, the forecast for 2026 places the average at $69.66 with neutral sentiment, before a sustained rise in subsequent years.
A major floor 9.0% below — a decisive break under it would weaken the trend.
The nearest floor, 5.4% below — buyers have tended to step in here.
Price is pressing into resistance (2.7% away) — a breakout level to watch.
A major ceiling 24.3% above — clearing it would confirm fresh momentum.
Key ALC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $67.34 | Buy | $67.44 | Buy |
| MA 10 | $67.57 | Buy | $67.36 | Buy |
| MA 20 | $66.87 | Buy | $67.15 | Buy |
| MA 50 | $66.90 | Buy | $68.35 | Sell |
| MA 100 | $72.87 | Sell | $71.21 | Sell |
| MA 200 | $75.28 | Sell | $75.00 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.50 | Neutral |
| Stoch RSI (14) | 53.53 | Neutral |
| CCI (20) | 64.74 | Neutral |
| Williams %R (14) | -41.29 | Info |
| MACD (12,26,9) | 0.14 | Buy |
| ROC (12) | 2.56 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 58.71 | Neutral |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | 0.67 | Buy |
| Ultimate (7,14,28) | 56.89 | Neutral |
| Momentum (10) | -0.32 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 66.91 | Buy |
| ADX (14) | 10.21 | Neutral |
| ATR (14) | 0.90 | Info |
The 30-day technical picture is bullish. RSI(14) stands at 60, indicating constructive momentum. The 50-day simple moving average sits at $67.75, while the 200-day moving average sits at $75.54, suggesting a near-term chart with a solid upward tilt but a longer-term average already above the current price.
The stock trades between support at $64.14 and a nearby resistance at $69.66, with a 30-day price range from $63.13 up to $76.87.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $62.02 | $67.81 | $91.10 | 0% | Neutral | |
| $69.51 | $84.87 | $108.35 | +25% | Bullish | |
| $78.57 | $97.74 | $128.15 | +44% | Bullish | |
| $84.27 | $106.44 | $142.53 | +57% | Bullish | |
| $82.84 | $106.05 | $144.56 | +56% | Bullish | |
| $87.55 | $113.46 | $157.11 | +67% | Bullish | |
| $93.59 | $122.64 | $172.24 | +81% | Bullish | |
| $102.00 | $135.08 | $192.16 | +99% | Bullish | |
| $116.44 | $155.74 | $224.20 | +130% | Bullish | |
| $124.32 | $167.85 | $244.32 | +148% | Bullish | |
| $160.14 | $225.50 | $343.98 | +233% | Bullish | |
| $284.31 | $429.38 | $702.08 | +533% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $62.02 | $67.81 | $80.62 | +0.00% |
| August 2026 | $60.33 | $70.63 | $84.48 | +4.15% |
| September 2026 | $61.60 | $72.46 | $87.35 | +2.60% |
| October 2026 | $60.78 | $71.78 | $87.10 | -0.93% |
| November 2026 | $60.78 | $72.04 | $87.89 | +0.35% |
| December 2026 | $62.48 | $74.29 | $91.10 | +3.13% |
Click any year to see its month-by-month ALC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ALC to range from $62.02 to $91.10 through 2026. The $67.81 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ALC price prediction for 2027 points to an average of $84.87 (low $69.51, high $108.35) — a potential gain of +25% on today's $67.81. Momentum favours further upside here.
In 2028, ALC is projected to trade between $78.57 and $128.15, averaging $97.74 — a potential gain of +44% from today's $67.81. That is up +15% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Alcon Inc.'s 2029 outlook centres on $106.44, within a $84.27 to $142.53 range. That is up +9% on the projected 2028 average. That marks a +57% change versus current levels. Momentum favours further upside here.
By 2030, ALC could reach as high as $144.56, with a base case around $106.05 and support toward $82.84 — roughly +56% from $67.81. Buyers look set to stay in control over this stretch.
Expect ALC to range from $87.55 to $157.11 through 2031. The $113.46 average target implies a +67% move from current prices. That is up +7% on the projected 2030 average. Momentum favours further upside here.
The ALC price prediction for 2032 points to an average of $122.64 (low $93.59, high $172.24) — a potential gain of +81% on today's $67.81. Buyers look set to stay in control over this stretch.
In 2033, ALC is projected to trade between $102.00 and $192.16, averaging $135.08 — a potential gain of +99% from today's $67.81. That is up +10% on the projected 2032 average. Momentum favours further upside here.
Alcon Inc.'s 2034 outlook centres on $155.74, within a $116.44 to $224.20 range. That is up +15% on the projected 2033 average. That marks a +130% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ALC could reach as high as $244.32, with a base case around $167.85 and support toward $124.32 — roughly +148% from $67.81. Momentum favours further upside here.
Expect ALC to range from $160.14 to $343.98 through 2040. The $225.50 average target implies a +233% move from current prices. That is up +34% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ALC price prediction for 2050 points to an average of $429.38 (low $284.31, high $702.08) — a potential gain of +533% on today's $67.81. Momentum favours further upside here.
Investing $1,000 in ALC today (≈ 14.747087 ALC) could be worth
$6,332.13
+$5,332.13 (+533%) by 2050 · US Dollar
Based on the average projected ALC price of $429.38 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALCwould be worth at today's price.
$1,000 invested in ALC on Jul 10, 2025 (≈ 11.273958 ALC) would be worth
$764.49
-$235.51 (-23.6%) today · 0.76× · US Dollar
Based on a ALC entry price of $88.7 vs. today's $67.81.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $69.66 | $973.44 | -2.7% |
| 1 month ago | $66.11 | $1,025.71 | +2.6% |
| 3 months ago | $78.01 | $869.25 | -13.1% |
| 6 months ago | $80.86 | $838.61 | -16.1% |
| 1 year ago | $88.7 | $764.49 | -23.6% |
| All time (5.0y) ago | $70.64 | $959.94 | -4.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALC forecast.
Our base-case forecast reaches $140.00 around 2034.
Implied market cap at $140.00: $68.28B
The multi-year forecast points to a pronounced upside, with the average price rising from $69.66 in 2026 to higher levels across the decade. By 2030, the average forecast is $111.06 with an ROI of 59.4% and a bullish sentiment; by 2040 the average forecast reaches $248.59 with an ROI of 256.9% and continued bullishness; and by 2050 the average forecast surges to $471.59 with an ROI of 577% and a sustained bullish outlook. The path includes intermediate years where the average moves from $88.32 in 2027 to $102.50 in 2028 and $111.99 in 2029, with progressively higher ROIs along the way.
These projections indicate substantial long-term upside but are estimates and not guarantees, and they should be considered in the context of market volatility and sector dynamics.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $111.06, with a low of $86.72 and a high of $151.44, and an ROI of 59.4%. These are projections and not guaranteed.
The outlook turns bullish from 2027 onward, with rising average prices and ROIs (e.g., 2027 avg $88.32, ROI 26.8%; 2030 avg $111.06, ROI 59.4%; 2050 avg $471.59, ROI 577%), but the 2026 projection is neutral. These are estimates, not guarantees.
Yes. The 2050 forecast shows an average price of $471.59, with a low of $312.21 and a max of $771.19, and an ROI of 577%.
Current price is $69.66 and market cap is $33.97B.
The 30-day range is $63.13 to $76.87, RSI(14) is 60, SMA50 is $67.75, SMA200 is $75.54, with support at $64.14 and resistance at $69.66.
Alcon Inc. Community Discussion
0Share your Alcon Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.